R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study. - Venkatraman N; Silman D; Bellamy D; Stockdale L; Bowyer G; Edwards NJ; Griffiths O; Lopez FR; Powlson J; Mair C; Folegatti PM; Datoo MS; et al. (The Lancet. Microbe, 2025)